Balang, Samera .

HRN: 24-53-30  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/11/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/11/2026
05/17/2026
IV
2.25gm
Q6h
DM FOOT
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines